Ulisse Biomed S.p.A. (BIT:UBM)
 1.020
 +0.020 (2.00%)
  Nov 3, 2025, 2:38 PM CET
Ulisse Biomed Balance Sheet
Financials in millions EUR. Fiscal year is January - December.
 Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year  | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2018 - 2019 | 
|---|---|---|---|---|---|---|---|
Period Ending  | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2018 - 2019 | 
Cash & Equivalents     | 1.06 | 1.5 | 2.79 | 3.79 | 4.99 | 0.04 | Upgrade   | 
Cash & Short-Term Investments     | 1.06 | 1.5 | 2.79 | 3.79 | 4.99 | 0.04 | Upgrade   | 
Cash Growth     | -13.41% | -46.06% | -26.51% | -23.97% | 11498.55% | -94.46% | Upgrade   | 
Accounts Receivable     | 0.35 | 0.3 | 0.53 | 0.13 | 0.23 | 0.37 | Upgrade   | 
Other Receivables     | 1.29 | 1.65 | 1.78 | 0.91 | 0.93 | 0.4 | Upgrade   | 
Receivables     | 1.64 | 1.94 | 2.31 | 1.04 | 1.16 | 0.77 | Upgrade   | 
Inventory     | 1.83 | 1.8 | 1.99 | 0.13 | 0.09 | 0.07 | Upgrade   | 
Total Current Assets     | 4.54 | 5.24 | 7.08 | 4.96 | 6.24 | 0.89 | Upgrade   | 
Property, Plant & Equipment     | 2.12 | 2.19 | 2.38 | 0.11 | 0.07 | 0.11 | Upgrade   | 
Goodwill     | 17.43 | 18.59 | 20.92 | - | - | - | Upgrade   | 
Other Intangible Assets     | 0.87 | 0.91 | 1.11 | 0.9 | 0.91 | 0.86 | Upgrade   | 
Long-Term Deferred Charges     | 0.06 | 0.22 | 0.4 | 0.59 | 0.79 | - | Upgrade   | 
Other Long-Term Assets     | 0.04 | 0.12 | 0.16 | 0.01 | 0.01 | 0.01 | Upgrade   | 
Total Assets     | 25.06 | 27.28 | 32.05 | 6.57 | 8.02 | 1.87 | Upgrade   | 
Accounts Payable     | 1.16 | 1.39 | 1.95 | 0.19 | 0.25 | 0.24 | Upgrade   | 
Accrued Expenses     | 0.06 | 0.09 | 1.07 | 0.06 | 0.02 | 0 | Upgrade   | 
Short-Term Debt     | 0.03 | 0.11 | 0.08 | 0.01 | 0 | 0 | Upgrade   | 
Current Income Taxes Payable     | 0.24 | 0.29 | 0.39 | 0 | 0.02 | 0.03 | Upgrade   | 
Current Unearned Revenue     | - | - | - | 0.1 | - | - | Upgrade   | 
Other Current Liabilities     | 0.31 | 0.27 | 0.55 | 0.06 | 0.07 | 0.03 | Upgrade   | 
Total Current Liabilities     | 1.8 | 2.15 | 4.05 | 0.41 | 0.37 | 0.3 | Upgrade   | 
Long-Term Debt     | 0.97 | 0.22 | 0.41 | - | - | - | Upgrade   | 
Long-Term Unearned Revenue     | 0.82 | 0.98 | - | 0.2 | 0.4 | - | Upgrade   | 
Other Long-Term Liabilities     | 0.24 | 0.26 | 0.23 | 0.02 | 0 | 0.01 | Upgrade   | 
Total Liabilities     | 3.82 | 3.61 | 4.7 | 0.63 | 0.77 | 0.31 | Upgrade   | 
Common Stock     | 0.24 | 0.24 | 0.22 | 0.08 | 0.08 | 0.05 | Upgrade   | 
Additional Paid-In Capital     | 39.52 | 39.52 | 37.28 | 11.22 | 11.22 | 4.95 | Upgrade   | 
Retained Earnings     | -19.19 | -16.76 | -10.82 | -6.02 | -4.71 | -4.11 | Upgrade   | 
Comprehensive Income & Other     | 0.66 | 0.66 | 0.67 | 0.67 | 0.67 | 0.67 | Upgrade   | 
Shareholders' Equity     | 21.24 | 23.67 | 27.35 | 5.95 | 7.25 | 1.56 | Upgrade   | 
Total Liabilities & Equity     | 25.06 | 27.28 | 32.05 | 6.57 | 8.02 | 1.87 | Upgrade   | 
Total Debt     | 1 | 0.33 | 0.5 | 0.01 | 0 | 0 | Upgrade   | 
Net Cash (Debt)     | 0.06 | 1.17 | 2.29 | 3.79 | 4.99 | 0.04 | Upgrade   | 
Net Cash Growth     | -92.73% | -48.94% | -39.49% | -24.07% | 11611.25% | -94.50% | Upgrade   | 
Net Cash Per Share     | 0.00 | 0.05 | 0.11 | 0.47 | 0.62 | - | Upgrade   | 
Filing Date Shares Outstanding     | 24.48 | 24.48 | 21.57 | 8.06 | 8.06 | - | Upgrade   | 
Total Common Shares Outstanding     | 24.48 | 24.48 | 21.57 | 8.06 | 8.06 | - | Upgrade   | 
Working Capital     | 2.74 | 3.09 | 3.03 | 4.55 | 5.87 | 0.59 | Upgrade   | 
Book Value Per Share     | 0.87 | 0.97 | 1.27 | 0.74 | 0.90 | - | Upgrade   | 
Tangible Book Value     | 2.94 | 4.16 | 5.32 | 5.05 | 6.34 | 0.7 | Upgrade   | 
Tangible Book Value Per Share     | 0.12 | 0.17 | 0.25 | 0.63 | 0.79 | - | Upgrade   | 
Machinery     | 2.86 | 2.84 | - | 0.29 | 0.21 | - | Upgrade   | 
Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.